Lexaria Bioscience Corp. (LEXX) stock rises today: Let’s find out why
Lexaria Bioscience Corp. (LEXX) stock announced today on June 3, 2021, that remdesivir and ebastine were effective when processed with its DehydraTECH in the prevention of the COVID-19 SARS-CoV-2. Following this announcement, LEXX stock happened to be green, and its stock price saw a push of 3.76% to reach $6.35 a share at the time […]
Lexaria Bioscience Corp. (LEXX) stock soars during pre-market trading. Let’s find out why?
Lexaria Bioscience Corp. (NASDAQ: LEXX) stock gained by 0.74% at last close while the LEXX stock price rises by 10.11% in the pre-market trading session. DehydraTECH, a Lexaria Bioscience patented drug delivery system, enhances the way active medicinal ingredients (APIs) reach the bloodstream by encouraging healthier oral absorption approaches and increasing the efficacy of fat-soluble […]
Lexaria Bioscience Corp (LEXX) stock ended the week with a loss in the after-market session
Lexaria Bioscience Corp. (LEXX) plunged 7.99% at $5.76 in after-market trading hours on Friday, May 7, 2021. The stock of LEXX gained 1.95% to complete the last trading session at $6.26. The price range of the company’s shares was between $5.51 and $6.99. LEXX’s shares have gained 23.72% in the last five days, while they […]
Lexaria Biosciences Corp. (NASDAQ: LEXX) stock gains in the current market. Here’s what you should know?
Lexaria Biosciences Corp. (NASDAQ: LEXX) stock rises by 18.49% during current market trading. DehydraTECH, a novel drug delivery system developed by Lexaria Biosciences, changes the way active medicinal ingredients reach the bloodstream by encouraging healthier oral absorption approaches and increasing the efficacy of fat-soluble active molecules, resulting in lower total dosing. What is happening? LEXX […]
